Hutch News

Hutch News

Stories tagged 'B cell'

Replenishing immune cells after remission

New approach, not yet tested in humans, aims to restore immune-powering B cells in cancer patients following successful CAR T-cell therapy

Oct. 17, 2016 | By Bill Briggs / Fred Hutch News Service

Scientists at Fred Hutch, Seattle Children’s Research Institute, and Technical University of Munich showed that activating a “kill switch” can turn off CAR T cells after doctors deem a cancer defeated, allowing normal B cells to again flourish.

View story >

Good News at Fred Hutch

Celebrating faculty and staff achievements

May 5, 2016

Applicants wanted for most inclusive fellowship program among top cancer centers; Dr. Oliver Press honored as new Giuliani/Press Endowed Chair; possible new path to targeted therapies for certain leukemias, myelodysplastic syndrome.

View story >

Good news at Fred Hutch: Celebrating our achievements

March 12, 2015 | By Fred Hutch staff

Notable accomplishments: Dr. Hans-Peter Kiem and colleagues explore new source of stem cells and gene therapy; Dr. Justin Taylor publishes a paper describing the path or paths individual naive B cells can take to maturity; Graduate student Nitobe London among 2015 Weintraub award winners

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.